Co-founder Bertilla Wong said her sister’s health took a turn for the worse in February during her two-week stay in South ...

This report describes a usually mild syndrome, dubbed LICATS, affecting about three-quarters of CAR T-cell recipients.

The apparent success — and now almost ever-present ubiquity — of GLP-1 receptor agonists in weight loss has led to research, and possible uses, far beyond its initial indications in diabetes, ...

Rheumatologists and dermatologists highlight Saphnelo, Sotyktu, and litifilimab as leading candidates to address unmet needs in CLE patients, particularly those with systemic involvementEXTON, PA, ...

US-based biopharmaceutical company Cullinan Therapeutics is due to begin a domestic trial of its drug candidate CLN-978 for ...

Living in areas with lower COI levels was associated with more severe disease presentation and poorer disease control among patients with cSLE.

A new literature review explores the emerging application of CAR-T cell therapy in treating people with Systemic Lupus ...

In a new study, researchers evaluated the potential relationship between disordered eating attitudes and nutritional status ...

Kangpu Biopharmaceuticals, Ltd. announced today that the Center for Drug Evaluation (CDE) of China's National Medical ...

The cell and gene therapy company is cutting 47 employees and its entire lupus program to focus resources on two CAR Ts. The ...

When most people think about arthritis or lupus, they picture adults. But for a small number of Malaysian children, these conditions ...